Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
- 28 January 2005
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 326 (4), 905-908
- https://doi.org/10.1016/j.bbrc.2004.11.128
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Temporal Relationship of Viral Load, Ribavirin, Interleukin (IL)–6, IL‐8, and Clinical Progression in Patients with Severe Acute Respiratory SyndromeClinical Infectious Diseases, 2004
- Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S ProteinJournal of Virology, 2004
- Role of interferons in the treatment of severe acute respiratory syndromeExpert Opinion on Biological Therapy, 2004
- Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral DrugsEmerging Infectious Diseases, 2004
- Severe Acute Respiratory Syndrome–Related Coronavirus Is Inhibited by Interferon‐αThe Journal of Infectious Diseases, 2004
- Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.2004
- Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory SyndromeJAMA, 2003
- Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirusThe Lancet, 2003
- Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation: Technical NoteKidney International, 1997
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984